DSM-Firmenich guided for proforma adjusted earnings of up to €1.9 billion in 2023, below the previous year, as it said vitamin prices are expected to remain low until the end of the year.
DSM-Firmenich guided for proforma adjusted earnings of up to €1.9 billion in 2023, below the previous year, as it said vitamin prices are expected to remain low until the end of the year.